Immediate-release and XR products represent different stages in delivery-system development: adding delayed release changes the exposure pattern without making the mixture a different set of active enantiomers. Historical brand recognition should therefore not be treated as proof that every preparation is equivalent.
The reviewed US immediate-release label was updated in 2024 and the XR label in 2026. Their safety and population boundaries need current checking. The UK catalogue's import designation and a local NHS service's prescribing policy address separate questions from US authorisation.